Testing effectiveness (Phase 2)Study completedNCT03192202What this trial is testingAFM13 in Relapsed/Refractory Cutaneous LymphomasWho this might be right forLymphoma, T-Cell, Cutaneous Ahmed Sawas 18
Early research (Phase 1)Study completedNCT01567709What this trial is testingAlisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT06468267What this trial is testingRIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.Who this might be right forPeripheral T Cell Lymphoma Xianmin Song, MD 50
Very early researchEnded earlyNCT01878708What this trial is testingA Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell LymphomaWho this might be right forT-Cell LymphomaRelapsed T-Cell LymphomaRefractory T-Cell Lymphoma Dana-Farber Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT03409432What this trial is testingBrentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell LymphomaWho this might be right forLymphomatoid PapulosisPrimary Cutaneous Anaplastic Large Cell LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma+6 more John Reneau 26
Large-scale testing (Phase 3)Study completedNCT03349333What this trial is testingA Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCLWho this might be right forRefractory Peripheral T-Cell LymphomaRelapsed T-Cell Lymphoma Mundipharma (China) Pharmaceutical Co. Ltd 85
Early research (Phase 1)Ended earlyNCT00671112What this trial is testingEverolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaWho this might be right for714leukemiaLymphoma Brian Hill, MD, PhD 30
Early research (Phase 1)Study completedNCT01134341What this trial is testingPralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaWho this might be right forCutaneous T-cell LymphomaMycosis FungoidesSezary Syndrome+1 more Acrotech Biopharma Inc. 34
Not applicableStudy completedNCT00856388What this trial is testingFludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more Roswell Park Cancer Institute 62
Not applicableStudy completedNCT00376922What this trial is testingMusic in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+7 more Wake Forest University Health Sciences 65
Testing effectiveness (Phase 2)UnknownNCT04917250What this trial is testingGPED for Patients With Relapsed/Refractory or Advanced NK/T-cell LymphomaWho this might be right forExtranodal NK/T-cell Lymphoma Beijing Tongren Hospital 15
Early research (Phase 1)UnknownNCT03921879What this trial is testingSafety and Efficacy of OT-82 in Participants With Relapsed or Refractory LymphomaWho this might be right forLymphomaLymphoma, Non-HodgkinLymphoma, B-Cell+4 more Oncotartis, Inc. 50
Very early researchNot Yet RecruitingNCT07213882What this trial is testingA Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL)Who this might be right forCutaneous T Cell Lymphoma (CTCL)Mycosis FungoidesSezary Syndrome Assistance Publique - Hôpitaux de Paris 30
Early research (Phase 1)Active Not RecruitingNCT04288726What this trial is testingAllogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive LymphomasWho this might be right forExtranodal Natural Killer/T-Cell Lymphoma, Nasal TypeClassical Hodgkin Lymphoma Baylor College of Medicine 27
Early research (Phase 1)Study completedNCT01606878What this trial is testingCrizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell LymphomaWho this might be right forChildhood Solid NeoplasmRecurrent Childhood Anaplastic Large Cell LymphomaRecurrent Neuroblastoma Children's Oncology Group 46
Early research (Phase 1)Looking for participantsNCT03829540What this trial is testingCD4CAR for CD4+ Leukemia and LymphomaWho this might be right forT-cell LymphomaT-cell Leukemia Huda Salman 20
Testing effectiveness (Phase 2)UnknownNCT04705090What this trial is testingYY-20394 in Patients With Relapsed or Refractory Peripheral T/NK Cell LymphomaWho this might be right forPTCL Shanghai YingLi Pharmaceutical Co. Ltd. 90
Early research (Phase 1)Study completedNCT01129180What this trial is testingBortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+9 more Pierluigi Porcu 8
Testing effectiveness (Phase 2)Looking for participantsNCT06244368What this trial is testingGVM±R in Patients With Relapsed or Refractory Aggressive NHL.Who this might be right forPeripheral T Cell LymphomaDiffuse Large B-cell Lymphoma Institute of Hematology & Blood Diseases Hospital, China 115